| I can't get a signal http://www.escinsellik.net/ssmhealthcompaymybill-3e83.pdf ssmhealth.com/walgreens "Lu AE58054 potentially represents a new approach to Alzheimer's disease and a continuation of Lundbeck's commitment to addressing this complicated disease", says Executive Vice President Anders Gersel Pedersen, the head of Lundbeck's R&D division. "It is my hope that the clinical phase III program will confirm results seen from this phase II trial, and demonstrate a positive outcome on this devastating disease.
|
